June 13, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 8,467 shares of Abrdn Life Sciences Investors at $13.82 per share, a transaction worth $117.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.